HealthRecordCommunity

News

1,676 FHIR-related articles (latest first)

International: 1,676 articles
FHIRInternational๐Ÿ›Health Level Seven International (HL7)EnrichedJun 20, 2025

How FHIR Addresses Healthcare Data Interoperability Challenges and Core Capabilities

To resolve inconsistencies and inefficiencies in data between electronic health record (EHR) systems, the Health Level Seven International (HL7) group developed Fast Healthcare Interoperability Resources (FHIR), a next-generation standard. FHIR aims to improve patient care and operational efficiency by providing a mechanism that allows diverse healthcare apps and systems to exchange data seamlessly using modern web technologies.

FHIRInternational๐Ÿ›๏ผˆใƒกใƒผใƒซ่ฉณ็ดฐใ‹ใ‚‰ๅ–ๅพ—ๅฏ๏ผ‰EnrichedJun 20, 2025

FHIR Environment Setup Guide: Steps and Tools for Development

This article provides a detailed, step-by-step guide on setting up a local development environment. It instructs users how to build an operational FHIR server within the InterSystems IRIS for Health Community using tools like VS Code and Docker, providing a practical foundation for API querying and script creation.

FHIRInternational๐Ÿ›MOLIT Service GmbHEnrichedJun 17, 2025

HL7 FHIRยฎ Utilization: Standard Foundation for Healthcare Data Exchange

The article explains that FHIR (Fast Healthcare Interoperability Resources) is an internationally established standard for electronic health data exchange. By combining modern web technologies like REST and JSON with a modular data modelโ€”the so-called 'Resources'โ€”FHIR enables structured, understandable, and interoperable communication in healthcare.

FHIRInternational๐Ÿ›LexisNexis ReedEnrichedJun 17, 2025

FHIR and the Future of Digital Labeling: What Manufacturers Need to Know

LexisNexis Reed Tech explains that FHIR is emerging as a key framework for exchanging product labeling information, driven by regulatory authorities and health systems pushing digital transformation. The webinar details how FHIR impacts medical device and pharmaceutical manufacturers, covering everything from electronic labeling (eLabeling) to streamlining updates across jurisdictions.

FHIR
FHIRInternationalEnrichedJun 15, 2025

Secondary Outcome for Safety Profile Comparison in Clinical Trials (CBD vs. Placebo)

This resource provides information on a secondary outcome measure (CTIS2024-513951-33-00) designed to evaluate safety differences between participants receiving CBD and those receiving placebo during clinical trials. The analysis focuses specifically on routine blood sample testing results and the Common Terminology Criteria for Adverse Events (CTCAE 5.0), with particular attention paid to the last week before End of Treatment (EOT).

FHIRInternational๐Ÿ›๏ผˆใƒกใƒผใƒซ่ฉณ็ดฐใ‹ใ‚‰ๅ–ๅพ—ๅฏ๏ผ‰EnrichedJun 14, 2025

Clinical Trial for Skin Disease: Evaluating Deucravacitinib's Efficacy in Lichen Planus

A multicenter, Phase II proof-of-concept study (DEUCRALIP) is evaluating the efficacy of the selective TYK2 inhibitor Deucravacitinib in lichen planus patients. The study assesses treatment effects by measuring changes in clinical symptoms and inflammatory parameters.